Hydreight Technologies Launches Updated Telehealth App for Mobile Wellness

The updated Hydreight Wellness app gives health and wellness professionals such as nurses greater control over their service offering, as well as robust technical support

VANCOUVER, British Columbia and LAS VEGAS, Dec. 29, 2022 (GLOBE NEWSWIRE) — Hydreight Technologies Inc. (“Hydreight” or the “Company“) (TSXV: NURS), a fast-growing telehealth platform and medical network, is pleased to announce the launch of its updated Hydreight Wellness App.

The Hydreight platform makes it possible for nurses and other licensed healthcare professionals across the U.S. to monetize their credentials and deliver health and wellness services independently, on their own terms. The platform has shown continuous growth month over month, adding nearly 650 of these business accounts in 2022 alone, a sixfold increase over 2021.

“This update delivers both aesthetic and functional upgrades with improved performance, usability, reporting, and overall functionality for both patients and service providers,” said Shane Madden, CEO of Hydreight. “We set out to create the infrastructure to make mobile healthcare and wellness a reality. Patients can find and book services as easily as they order an Uber or a DoorDash order, wherever they are, at their homes or on the road at their hotel.”

The Hydreight Wellness app update includes:

  • An improved booking experience that makes it easier for patients to schedule appointments
  • Monthly membership and subscription options that service providers can customize with one service or bundle of services to fit the needs of their patients
  • Enhanced onboarding support to make it easier to get up and running on the platform more quickly
  • Complete in-app training is now available for all user roles, with updates planned to accompany all future releases
  • Flexible payout dates can now be configured by the user, rather than being automatically set by the platform
  • Inventory management is now under the control of the user, making it easy for each service provider to add and remove inventory from their offering as desired

Hydreight supports a range of health and wellness professionals, making it possible for them to offer IV drip, Botox, COVID-19 testing, and other medical and med spa treatments all in the comfort of the patient’s home, office, hotel, or any other suitable location of their choosing.

“We have made it possible for healthcare to take place beyond the confines of hospitals and clinics,” added Madden. “With medical director oversight, access to a digital pharmacy, and compliance infrastructure deployed automatically by the platform, we are proud to be changing the lives of nurses and other health and wellness professionals, as well as the lives of their patients.”

Patients can download Hydreight from the Apple App store or Google Play Store, and prospective service providers can sign up at: Hydreight.com/start-a-business/

Hydreight Technologies Inc. (TSXV: NURS) is a telehealth platform and medical network that bridges the gap between provider compliance and patient convenience, empowering nurses, med spa technicians, and other licensed healthcare professionals to monetize their credentials and deliver services independently, on their own terms, or add mobile services to existing location-based operations. The network offers medical director oversight, liability insurance, HIPAA-compliant documentation, access to a digital pharmacy, and more. The platform includes a built-in, easy-to-use suite of fully-integrated tools for accounting, documentation, sales, inventory, booking, managing patient data, and more, making it possible to deliver fully-compliant mobile medicine across all 50 states. Learn more at Hydreight.com.

Patients can download Hydreight from the Apple App store or Google Play Store, and prospective service providers can sign up at: Hydreight.com/start-a-business/

On behalf of the Board of Directors

Shane Madden
Director and Chief Executive Officer
Hydreight Technologies Inc.
www.hydreight.com
Telephone: (480) 790 6886

For further information about Hydreight, please contact:

Investor Relations
Contact – Abbey Vogt
Email: ir@hydreight.com
Telephone: (480) 790 6886

Marketing and Media Contact- Jessica Friedman
Email: jess@hydreight.com
Telephone: (480) 790 6886

Neither TSXV nor its Regulation Services Provider (as that term is defined in policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release.

This press release does not constitute an offer of securities for sale in the United States. The securities being offered have not been, nor will they be, registered under the United States Securities Act of 1933, as amended, and such securities may not be offered or sold within the United States absent U.S. registration or an applicable exemption from U.S. registration requirements.

Cautionary Note Regarding Forward-Looking Information

This press release contains statements which constitute “forward-looking information” within the meaning of applicable securities laws, including statements regarding the plans, intentions, beliefs and current expectations of the Company with respect to future business activities and operating performance. Forward-looking information is often identified by the words “may”, “would”, “could”, “should”, “will”, “intend”, “plan”, “anticipate”, “believe”, “estimate”, “expect” or similar expressions and includes information regarding: expectations regarding the number of new business partners of Hydreight by the end of 2022.

Investors are cautioned that forward-looking information is not based on historical facts but instead reflect the Company’s management’s expectations, estimates or projections concerning future results or events based on the opinions, assumptions and estimates of management considered reasonable at the date the statements are made. Although the Company believes that the expectations reflected in such forward-looking information are reasonable, such information involves risks and uncertainties, and undue reliance should not be placed on such information, as unknown or unpredictable factors could have material adverse effects on future results, performance or achievements of the Company. Among the key factors that could cause actual results to differ materially from those projected in the forward-looking information are the following: the ability to obtain requisite regulatory and other approvals with respect to the business operated by the Company and/or the potential impact of the listing of the Company’s shares on the TSXV on relationships, including with regulatory bodies, employees, suppliers, customers and competitors; changes in general economic, business and political conditions, including changes in the financial markets; changes in applicable laws; compliance with extensive government regulation; and the diversion of management time as a result of being a publicly listed entity. This forward-looking information may be affected by risks and uncertainties in the business of the Company and market conditions.

Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward-looking information prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected. Although the Company has attempted to identify important risks, uncertainties and factors which could cause actual results to differ materially, there may be others that cause results not to be as anticipated, estimated or intended. The Company does not intend, and does not assume any obligation, to update this forward-looking information except as otherwise required by applicable law.

Staff

Recent Posts

cbdMD Announces Company’s CEO Joins the Board of Directors

Charlotte, North Carolina--(Newsfile Corp. - December 23, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE…

4 hours ago

Interactive Strength Inc. (Nasdaq: TRNR) Issues Year-End Update, Looks Ahead to 2025

AUSTIN, TEXAS / ACCESSWIRE / December 23, 2024 / Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or…

5 hours ago

Quest Diagnostics Upholds Strong Governance and Ethics With Robust Oversight, ESG Integration, and Comprehensive Risk Management

Originally published in Quest Diagnostics' 2023 Corporate Responsibility ReportNORTHAMPTON, MA / ACCESSWIRE / December 23,…

5 hours ago

Phio Pharmaceuticals Announces Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Marlborough, Massachusetts--(Newsfile Corp. - December 23, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage…

6 hours ago

ILiAD Biotechnologies Announces the Passing of Chief Operating Officer Ken Solovay

WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…

8 hours ago

ILiAD Biotechnologies Announces the Passing of Chief Operating Officer Ken Solovay

WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…

8 hours ago